Funding, M&A, exec moves and hiring — every signal, the moment it breaks.See plans →

Femasys Secures $30 Million in Private Placement Led by Nantahala Capital. This funding is aimed at supporting innovative fertility solutions and reducing costs for women's health.

PUBLIC · FEMYAug 07, 2026•about 12 hours ago

Amount Raised

$30 Million

Round Type

Post-IPO Equity

SuwaneeBiotechnologyHealth Care

Investors

Rosalind Advisors, Inc.Nantahala Capital

Description

Femasys Inc. has entered into a $30 million securities purchase agreement with accredited investors, with Nantahala Capital leading the financing round. The placement is expected to close on or around August 10, 2026, and is subject to customary closing conditions. This funding will help the company develop transformative fertility and non-surgical birth control solutions

Company Information

Company

Femasys

Location

3950 Johns Creek Court

Suwanee, Georgia, United States

About

Femasys Inc. is a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions. The company has a lead, late-clinical stage product candidate and innovative therapeutic and diagnostic products.

Related People

Suggested for you

1 contact

Verified contactsNo contacts on file at Femasys yet.

Predictive Intelligence

Strategic

ML-powered predictions for Femasys's next move

Learn about Strategic plan

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Watching Femasys? See every signal — funding, hires, M&A, contracts, sentiment.

Book a demo Choose your plan